[HTML][HTML] Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee… - Iranian Journal of …, 2021 - ncbi.nlm.nih.gov
Materials and Methods: A. baumannii (n= 112) isolates were recovered from various clinical
specimens of patients admitted in internal, surgery, burn, infectious diseases and various …

[PDF][PDF] Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee, B Baradaran… - 2021 - researchgate.net
ABSTRACT Background and Objectives: Carbapenem treatment for Acinetobacter
baumannii infections presently faces threats owing to the production of several types of …

Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync.

A Vahhabi, A Hasani, MA Rezaee… - Iranian Journal of …, 2021 - europepmc.org
Materials and methods A. baumannii (n= 112) isolates were recovered from various clinical
specimens of patients admitted in internal, surgery, burn, infectious diseases and various …

Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee, B Baradaran… - 2021 - agris.fao.org
Background and Objectives: Carbapenem treatment for Acinetobacter baumannii‎‎ infections
presently faces threats owing to the production of several types of carbapenemase enzymes …

Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee… - Iranian Journal of …, 2021 - publish.kne-publishing.com
Abstract Background and Objectives: Carbapenem treatment for Acinetobacter baumannii
infections presently faces threats owing to the production of several types of carbapenemase …

[HTML][HTML] Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee… - Iranian Journal of …, 2021 - ijm.tums.ac.ir
Abstract Background and Objectives: Carbapenem treatment for Acinetobacter baumannii‎‎
infections presently faces threats owing to the production of several types of carbapenemase …

[PDF][PDF] Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee, B Baradaran… - 2021 - pdfs.semanticscholar.org
ABSTRACT Background and Objectives: Carbapenem treatment for Acinetobacter
baumannii infections presently faces threats owing to the production of several types of …

Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync.

A Vahhabi, A Hasani, MA Rezaee… - Iranian Journal of …, 2021 - search.ebscohost.com
Abstract Background and Objectives: Carbapenem treatment for Acinetobacter baumannii
infections presently faces threats owing to the production of several types of carbapenemase …

Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

A Vahhabi, A Hasani, MA Rezaee… - Iranian journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background and objectives Carbapenem treatment for Acinetobacter baumannii infections
presently faces threats owing to the production of several types of carbapenemase enzymes …

Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync.

A Vahhabi, A Hasani, MA Rezaee, B Baradaran… - 2021 - cabidigitallibrary.org
Abstract Background and Objectives: Carbapenem treatment for Acinetobacter baumannii
infections presently faces threats owing to the production of several types of carbapenemase …